Dr. Bhawana Saddy Awasthy Medical Oncologist

Doctor Overview

• Full Name & Designation: Dr. Bhawana Saddy Awasthy, Senior Consultant – Medical Oncology
• Specialization(s): Medical Oncology, Clinical Oncology
• Years of Experience: 20+ Years (Clinical Practice), 30+ Years (Combined Clinical & Research)
• Current Hospital/Institution Affiliation: Fortis Hospital, Vasant Kunj, New Delhi; Syneos Health

Dr. Bhawana Saddy Awasthy is a highly respected Senior Consultant in Medical Oncology based in Delhi-NCR, bringing over two decades of dedicated clinical practice and more than 30 years of combined experience in patient care and clinical research. Following a significant 12-year tenure at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi, she transitioned to leading private hospitals. Dr. Awasthy specializes in the medical management of various solid tumors, particularly breast, ovarian, colorectal, and lung cancers, utilizing chemotherapy, immunotherapy, and targeted therapies. Alongside her clinical practice, she holds senior leadership roles in the clinical research industry, driving global drug development and oncology research initiatives. Her unique blend of deep clinical expertise and extensive research background ensures patients receive care informed by the latest advancements.

Qualifications & Credentials

Medical Degrees:

• MBBS
• MD Internal Medicine
• DNB Oncology

Areas of Expertise

Major Cancer Types Treated:

• Breast Cancer
• Ovarian Cancer
• Colorectal Cancer
• Lung Cancer
• Genitourinary Cancers
• Sarcomas
• Multiple Myeloma
• Head and Neck Cancers
• Bone Tumors
• Gastrointestinal Cancers
• Lymphomas

Sub-specialties:

• Medical Management of Solid Tumors
• Clinical Research & Drug Development (Phase I-IV Trials)
• Oncology Biomarker Research
• Translational Research

Advanced Procedures Performed/Treatments Offered:

• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Hormone Therapy
• Participation in Tumor Board Clinics
• Clinical Trial Enrollment

Professional Experience

Current & Past Hospital Affiliations:

• Senior Consultant – Oncology, Fortis Hospital, Vasant Kunj (Present)
• Consultant Oncologist – Various Reputed Hospitals in Delhi/NCR including CK Birla Hospital & Marengo Asia Hospitals

Academic & Research Roles:

• General Manager India, Vice President Medical & Scientific Management, Syneos Health (Present)
• Executive Medical Director/Senior Director, Medical Affairs, INC Research (May 2010 – Aug 2014)
• Founder, Clinical Research Consultant, Xcelerx Communications (2004 – Apr 2010)
• Head Clinical Research Services, Health Care Global Enterprises (HCG) (Sep 2006 – Jan 2010)
• Senior Clinical Research Physician, Eli Lilly & Co. (Aug 2001 – May 2004)
• Clinical Research & Teaching Roles at AIIMS

Key Achievements & Contributions:

• Extensive experience in designing, developing, and conducting oncology clinical trials (Phase I-IV).
• Played key roles in expanding oncology research operations in India (Eli Lilly).
• Instrumental in setting up research site networks, centralized processes, Biorepositories, and translational research projects.
• Planned oncology biomarker research capabilities for hospital networks.
• Managed global drug development and oncologist engagement activities.
• Developed research and ethics committee systems adhering to US FDA standards in India.

Research & Publications

Published Papers in Medical Journals: Has published numerous articles in peer-reviewed journals. A few are mentioned below:

• Carcinoma of the major salivary glands. analysis of the role of radiation therapy (1999)
• A multicenter phase II study of gemcitabine, paclitaxel, and cisplatin in chemonaïve advanced ovarian cancer (2005)
• A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer (2004)
• Chemotherapy in biliary tract carcinomas: results in India (2002)
• Paclitaxel-epirubicin in advanced breast cancer (1999)
• Effect of amifostine on toxicities associated with salvage combination chemotherapy (2001)
• A study of concurrent radiochemotherapy with paclitaxel in glioblastoma multiforme (2002)

Ongoing Clinical Trials Participation: Actively involved in clinical research strategy and potentially patient enrollment through her affiliations. Has extensive experience across all phases of clinical trials.

Patient Success Stories & Testimonials

Patient Testimonials

“Dr. Awasthy is a confident and compassionate doctor.” – R. Sharma

“Facing cancer was terrifying, but Dr. Awasthy’s systematic approach and knowledge of the latest treatments gave me hope. She explored all options, including clinical trials, and I felt I was in the best possible hands.” – A. Khan

“I consulted Dr. Awasthy for a second opinion on my ovarian cancer. Her thoroughness and ability to simplify complex information were remarkable. She coordinated seamlessly with my surgical team, and I’m doing well post-treatment.” – S. Verma

Treatment Approach & Philosophy

• Patient-Centred Care: Emphasizes genuine concern for patients, ensuring comfort and prompt attention (as per Lybrate). Focuses on clear communication and involving patients in decision-making.
• Evidence-Based Medicine: Integrates extensive clinical research knowledge with clinical practice to offer treatments based on the latest scientific evidence.
• Multidisciplinary Approach: Utilizes Tumor Board Clinic based approaches for comprehensive treatment planning involving various specialists.
• Technology & Innovation: Involved in planning biomarker research and has deep experience in drug development, suggesting an approach open to innovative therapies and personalized medicine.

Consultation Fees & Treatment Costs

• Consultation Fees: The consultation charges of Dr. Bhawana Awasthy is around ₹2000.
• Treatment Costs: Vary significantly based on the type of cancer, stage, specific treatment plan (chemotherapy drugs, immunotherapy, targeted therapy), duration, and hospital charges. It’s best to discuss estimated costs directly with the hospital’s billing department after consultation and treatment planning.

International Patient Assistance

• Language Support: Contact Cancer Rounds for assistance with language requirements.
• Visa & Travel Assistance: Cancer Rounds typically has a dedicated International Patient Services desk to assist with visa applications, travel arrangements, and accommodation. The Cancer Rounds team coordinates all aspects of care, including scheduling appointments, diagnostic tests, treatment sessions (like chemotherapy or immunotherapy rounds), and follow-ups.
• Pre-treatment Virtual Consultations: Available for international patients to discuss their case and potential treatment options before traveling.

Frequently Asked Questions (FAQs)

 Q 1. How much experience does Dr. Bhawana Awasthy have?

She has over 20 years of clinical practice experience and over 30 years of combined experience in clinical oncology and clinical research.

Q 2. What types of cancer does Dr. Bhawana Awasthy treat most often?

Her clinical interests include cancers of the breast, ovary, colorectal, lung, genitourinary system, sarcomas, multiple myeloma, head & neck, and bone tumors.

Q 3. What is Dr. Awasthy’s approach to cancer treatment?

She follows a patient-centered, evidence-based approach, often utilizing multidisciplinary Tumor Boards. Her deep research background informs her use of advanced treatments like immunotherapy, targeted therapy, and potential clinical trial options.

Q 4. Does Dr. Saddy offer second opinions?

Yes, patients often consult experienced oncologists like Dr. Bhawana Saddy Awasthy for second opinions on their diagnosis and treatment plans.

Q 5. Is Dr. Bhawana Saddy Awasthy involved in clinical trials?

Yes, she has extensive experience in designing and conducting clinical trials and may facilitate patient enrollment in relevant studies, offering access to novel therapies.

Q 6. What makes Dr. Bhawana Saddy Awasthy’s profile unique?

Her unique profile combines extensive hands-on clinical oncology practice with high-level leadership experience in global clinical research and drug development, offering patients a perspective grounded in both care delivery and cutting-edge science.